SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News:
Aerocrine (STO:AEROB):
January – December 2011
Global Net sales grew by 10% to SEK 93.5m (84.7). Adjusted for currency fluctuations, net sales rose by 18% The worldwide number of NIOX MINO® repeat tests sold increased by a total of 20% and for clinical use in the US by 138%
